Jason Ramseth
Paradise Valley, Arizona, United States
1K followers
500+ connections
Paradise Valley, Arizona, United States
1K followers
500+ connections
About
A biopharmaceutical information technology executive with depth and breadth across all IT…
Articles by Jason
-
http://www.businessinsider.com/google-execs-advice-on-when-to-take-on-a-new-job-2016-5
http://www.businessinsider.com/google-execs-advice-on-when-to-take-on-a-new-job-2016-5
By Jason Ramseth
Activity
-
Cell therapy is in the middle of a huge shift... ...and everyone from small biotechs to big pharma want in on the next big thing: autoimmune…
Cell therapy is in the middle of a huge shift... ...and everyone from small biotechs to big pharma want in on the next big thing: autoimmune…
Liked by Jason Ramseth
-
When leaders don’t step up, the whole team suffers: Teams with uninspiring leaders are 50% less likely to come up with innovative solutions to…
When leaders don’t step up, the whole team suffers: Teams with uninspiring leaders are 50% less likely to come up with innovative solutions to…
Liked by Jason Ramseth
-
I am pleased to announce that I am joining knownwell, a metabolic health and weight-inclusive primary care group. I am thrilled to work with the…
I am pleased to announce that I am joining knownwell, a metabolic health and weight-inclusive primary care group. I am thrilled to work with the…
Liked by Jason Ramseth
Experience
-
Autolus, Eliem Therapeutics, Recludix, ProfoundBio, TrakCel, WhizAI, Circulants,
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Honors & Awards
-
"Leading Amgen's Future" Award
-
Honored for leadership level performance for biggest business impact while exemplifying behaviors and leadership attributes.
-
"Amgen First" Executive Leadership Development Program
-
-
Amgen Executive Leadership Development Program
-
-
Amgen Field Sales Management Development Program
-
Organizations
-
Advisory Board Member, Circulants
-
- Present
More activity by Jason
-
I’m excited to attend ASCO and I’m looking forward to see the latest CAR T data such as: - advancement in solid tumors, such as liver and gastric…
I’m excited to attend ASCO and I’m looking forward to see the latest CAR T data such as: - advancement in solid tumors, such as liver and gastric…
Liked by Jason Ramseth
-
Raghu Bharadwaj - The colleague who became more than a partner-in-cause....a genuine soul who became a close confidante and friend! The days/nights…
Raghu Bharadwaj - The colleague who became more than a partner-in-cause....a genuine soul who became a close confidante and friend! The days/nights…
Liked by Jason Ramseth
-
This coming weekend I will be taking part in Ride London 100. This is a 100 mile ride from The Embankment, out into Essex and back, finishing on…
This coming weekend I will be taking part in Ride London 100. This is a 100 mile ride from The Embankment, out into Essex and back, finishing on…
Liked by Jason Ramseth
-
I'm delighted to let you know have joined Sygnature Discovery as Chief Scientific Officer. https://lnkd.in/en2CsjuF This is a fantastic…
I'm delighted to let you know have joined Sygnature Discovery as Chief Scientific Officer. https://lnkd.in/en2CsjuF This is a fantastic…
Liked by Jason Ramseth
-
Yesterday, at our bi-annual Industry Advancement Board (IAB), we had the privilege of convening with some key players within Cell and Gene Therapy…
Yesterday, at our bi-annual Industry Advancement Board (IAB), we had the privilege of convening with some key players within Cell and Gene Therapy…
Liked by Jason Ramseth
-
Best video I've watched this year 💓 😍 💖 #kindness
Best video I've watched this year 💓 😍 💖 #kindness
Liked by Jason Ramseth
-
🚨 𝐓𝐡𝐞 𝐅𝐃𝐀 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐚 𝐧𝐞𝐰 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 First approval of its kind arrives as tumour-infiltrating lymphocyte (TIL)…
🚨 𝐓𝐡𝐞 𝐅𝐃𝐀 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐚 𝐧𝐞𝐰 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 First approval of its kind arrives as tumour-infiltrating lymphocyte (TIL)…
Liked by Jason Ramseth
-
Susan Michl is one of those women that walk into your orbit and “wow”! That was a very lucky day at FirstRule Group!
Susan Michl is one of those women that walk into your orbit and “wow”! That was a very lucky day at FirstRule Group!
Liked by Jason Ramseth
-
Thanks Kyle LaHucik for the engaging conversation and for featuring our work at ProfoundBio in Endpoints News. It was great to discuss our latest…
Thanks Kyle LaHucik for the engaging conversation and for featuring our work at ProfoundBio in Endpoints News. It was great to discuss our latest…
Liked by Jason Ramseth
-
2024 marks the end of a nearly 23 year career at BMS, (with detours to Juno Therapeutics, Celgene and back to BMS, along the way). I want to take…
2024 marks the end of a nearly 23 year career at BMS, (with detours to Juno Therapeutics, Celgene and back to BMS, along the way). I want to take…
Liked by Jason Ramseth
-
ProfoundBio is thrilled to announce the initiation of dosing in the Phase 1/2 clinical trial of PRO1107, marking a significant step forward in our…
ProfoundBio is thrilled to announce the initiation of dosing in the Phase 1/2 clinical trial of PRO1107, marking a significant step forward in our…
Liked by Jason Ramseth
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More